Sovereign Pharma Commissions India's First High-Volume Isolator-Based Ampoule Manufacturing Line
Sovereign Pharma has commissioned its first isolator-based filling line as part of a long-term modernisation plan to upgrade three of its filling lines to advanced isolator systems. The newly commissioned line is fully operational and marks a major milestone in the company’s shift toward next-generation sterile manufacturing.
Manufacturing | 12/12/2025 | By Darshana | 189
Eli Lilly Expands USA Manufacturing with Alabama Plant
The site will focus on producing synthetic and peptide-based medicines, including Lilly’s first oral GLP-1 weight-loss therapy, Orforglipron, which the company expects to submit for regulatory approval early next year.
Manufacturing | 11/12/2025 | By Darshana | 147
AsymBio Begins Operations at Fengxian Base to Boost Global CDMO Capacity
AsymBio has commenced commercial operations at its 130,000-square-metre Fengxian base, adding a major hub to its global CDMO network alongside its Shanghai Jinshan and Zhangjiang facilities. The new site is built to offer flexible, scalable support across all clinical phases, delivering customised CDMO solutions.
Manufacturing | 08/12/2025 | By Dineshwori | 173
Lemnisca Raises Pre-Seed Funding to Scale Bio-AI for Biomanufacturing
Theia Ventures, an India-based early-stage fund specialising in AI, deeptech, energy transition, and decarbonisation, has led a pre-seed investment in Lemnisca, a Bio-AI company developing intelligent systems to scale biomanufacturing.
Manufacturing | 01/12/2025 | By Darshana | 376
Thermo Fisher Opens Bioprocess Design Center in Hyderabad to Boost Biologics Manufacturing
Thermo Fisher Scientific has launched a new Bioprocess Design Center in Hyderabad to support India’s growing biologics and biopharmaceutical manufacturing ecosystem. The facility aims to help companies accelerate the development and scale-up of biologics, vaccines, and advanced therapies.
Manufacturing | 25/11/2025 | By Darshana | 280
AGC Biologics has partnered with AAVantgarde Bio to manufacture its dual-vector AAV gene therapies targeting inherited retinal disorders. Leveraging the BravoAAV platform, the collaboration aims to advance complex treatments designed to restore vision in patients with genetic blindness.
Manufacturing | 24/11/2025 | By Dineshwori | 262
AstraZeneca Plans USD 2 Billion Manufacturing Investment in Maryland
AstraZeneca will invest USD 2 billion to expand its biologics manufacturing in Maryland, boosting production of cancer, rare disease, and chronic therapies while supporting around 2,600 jobs.
Manufacturing | 24/11/2025 | By Dineshwori | 160
Moderna Onshores Full mRNA Drug Production to USA, Expands Norwood Facility
Moderna, Inc. announced a major expansion of its U.S. manufacturing operations by bringing drug product manufacturing to its Moderna Technology Center (MTC) in Norwood, Massachusetts. With this onshoring move, the company will now manage complete end-to-end manufacturing for its mRNA medicines within the United States.
Manufacturing | 21/11/2025 | By Darshana | 224
Apriori Bio, A*STAR IDL Partner to Develop Next-Gen AI-Designed saRNA Flu Vaccines
Apriori Bio, a Flagship Pioneering company focused on creating variant-resilient vaccines, has announced a strategic research partnership with the ASTAR Infectious Diseases Labs (ASTAR IDL) to co-develop next-generation self-amplifying RNA (saRNA) vaccines for seasonal and pandemic influenza.
Manufacturing | 19/11/2025 | By Darshana | 254
Rockwell Automation Expanding US Footprint with New Greenfield Manufacturing Site
Rockwell Automation to build new greenfield manufacturing site in Southeastern Wisconsin as part of its USD 2 billion investment plan to strengthen US manufacturing and digital capability.
Manufacturing | 19/11/2025 | By Dineshwori | 207
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy